Stock NVRO NEVRO CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Nevro Corp.

Equities

NVRO

US64157F1030

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
12.32 USD +0.24% Intraday chart for Nevro Corp. -6.10% -42.75%
Apr. 15 RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating MT
Apr. 11 Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating MT

Business Summary

Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.

Number of employees: 1,215

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical Devices
100.0 %
406 100.0 % 425 100.0 % +4.63%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
86.2 %
348 85.7 % 367 86.2 % +5.28%
International
13.8 %
58 14.3 % 59 13.8 % +0.72%

Managers

Managers TitleAgeSince
Kevin Thornal CEO
 Chief Executive Officer 50 23-04-23
D. Grossman CHM
 Chairman 63 19-03-18
Roderick MacLeod DFI
 Director of Finance/CFO 57 20-06-14
Donald Middlebrook CTO
 Chief Tech/Sci/R&D Officer 73 20-01-19
Geeta Kaveti CMP
 Compliance Officer - -
Christopher Christoforou CTO
 Chief Tech/Sci/R&D Officer 54 16-06-30
Kerry Bradley CTO
 Chief Tech/Sci/R&D Officer - -
David Caraway CTO
 Chief Tech/Sci/R&D Officer 67 14-03-31
Michael DeMane BRD
 Director/Board Member 67 11-03-16
Angeline McCabe IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Michael DeMane BRD
 Director/Board Member 67 11-03-16
Karen Prange BRD
 Director/Board Member 60 19-12-16
D. Grossman CHM
 Chairman 63 19-03-18
Elizabeth Weatherman BRD
 Director/Board Member 64 19-03-18
Kevin O'Boyle BRD
 Director/Board Member 68 19-03-18
Frank Fischer BRD
 Director/Board Member 82 12-09-30
Susan Siegel BRD
 Director/Board Member 63 20-12-01
Shawn McCormick BRD
 Director/Board Member 59 14-08-31
Sridhar Kosaraju BRD
 Director/Board Member 46 21-08-30
Kevin Thornal CEO
 Chief Executive Officer 50 23-04-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,364,308 35,473,980 ( 94.94 %) 682,916 ( 1.828 %) 94.94 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.17 %
4,067,271 11.17 % 59 M $
Armistice Capital LLC
8.726 %
3,176,000 8.726 % 46 M $
BlackRock Advisors LLC
8.566 %
3,117,732 8.566 % 45 M $
ArrowMark Colorado Holdings LLC
8.273 %
3,011,059 8.273 % 43 M $
Engaged Capital LLC
5.957 %
2,168,163 5.957 % 31 M $
Engaged Capital LLC
5.957 %
2,168,163 5.957 % 31 M $
Weatherbie Capital LLC
5.822 %
2,119,266 5.822 % 31 M $
Braidwell LP
4.880 %
1,776,368 4.880 % 26 M $
D.E. Shaw & Co., Inc.
3.305 %
1,202,984 3.305 % 17 M $
Fidelity Management & Research Co. LLC
2.983 %
1,085,631 2.983 % 16 M $

Company contact information

Nevro Corp.

1800 Bridge Parkway

94065, Redwood City

+650 251 0005

http://www.nevro.com
address Nevro Corp.(NVRO)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per region

Ratings for Nevro Corp.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
12.32 USD
Average target price
17.73 USD
Spread / Average Target
+43.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NEVRO CORP. Stock Nevro Corp.
-42.75% 452M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.36% 183B
MEDTRONIC PLC Stock Medtronic plc
-3.87% 105B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.38% 67.36B
DEXCOM, INC. Stock DexCom, Inc.
+8.23% 51.77B
CENCORA, INC. Stock Cencora, Inc.
+15.54% 47.29B
HOYA CORPORATION Stock Hoya Corporation
-1.73% 40.2B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+7.16% 27.62B
SARTORIUS STEDIM BIOTECH Stock Sartorius Stedim Biotech
-16.62% 21.75B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
-1.68% 25.51B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NVRO Stock
  4. Company Nevro Corp.